Wang Zhong-gao, Li Chun-min, Gu Yong-quan, Yu Heng-xi, Chen Bing, Guo Lian-rui, Li Xue-feng, Cui Shi-jun, Li Zhen
Department of Vascular Surgery, Xuanwu Hospital, the Capital Medical University, Beijing 100053, China.
Zhonghua Wai Ke Za Zhi. 2008 Aug 1;46(15):1149-52.
To investigate the management of complicated, severe or recurrent Budd-Chiari syndrome.
From February 2004 to August 2007, 28 patients with complicated, severe or recurrent Budd-Chiari syndrome were treated. In this series, 16 patients relapsed after treated with percutaneous transluminal angioplasty or stent deployment, 2 cases relapsed after surgery; and the other 10 were under severe conditions and hard to treat, including malignancy of the inferior vena cava and right atrium. Meso-cavo-atrial shunt was carried out in 10 cases, meso-cavo-jugular shunt in 6 (capitis medusa was used in one case), cavoatrial shunt in 2 and cavo-jugular shunt in 1, mesocaval shunt in 2, and radical or extended radical correction in 7.
One patient (3.6%) died in 24 hours after operation. Graft infection occurred in 1 case. Excellent, good, fair, poor and death rate were 22.2%, 55.5%, 14.8%, 3.7% and 3.7%, respectively, the overall effective rate was 92.5%.
To select personalized treatment according to the disease status brings hopes to difficult, severe, recurrent Budd-Chiari syndrome.